Valneva Reports 94% IXCHIQ Antibody Response at Five Years
Lyon, France, November 10, 2026 Valneva SE, a specialty vaccine company, has announced positive five-year antibody persistence results for...
VLA1553-303
Advertisement
Advertisement
